Tenon Medical Inc reports results for the quarter - Earnings Summary

Reuters
2024-11-14
Tenon Medical Inc reports results for the quarter - Earnings Summary
  • Tenon Medical Inc TNON.OQ reported a quarterly adjusted loss of $3.63​​ per share for the quarter , higher than the same quarter last year, when the company reported EPS of $-11.68. The mean expectation of two analysts for the quarter was for a loss of $4.23 per share. Wall Street expected results to range from $-6.16 to $-2.31 per share.

  • Revenue fell 6% to $887.00 thousand from a year ago; analysts expected $1.19 million.

  • Tenon Medical Inc's reported EPS for the quarter was a loss of $3.63​.

  • The company reported a quarterly loss of $3.18 million.

  • Tenon Medical Inc shares had fallen by 18.9% this quarter and lost 72.8% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had risen by about 37.7% in the last three months.​

  • In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Tenon Medical Inc is $22.00

This summary was machine generated from LSEG data November 14 at 04:17 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Sep. 30 2024

-4.23

-3.63

Beat

Jun. 30 2024

-8.68

-8.16

Beat

Mar. 31 2024

-10.72

-10.00

Beat

Dec. 31 2023

-11.04

-5.44

Beat

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10